Compare RYZ & ATRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RYZ | ATRC |
|---|---|---|
| Founded | 1842 | 2000 |
| Country | United States | United States |
| Employees | 4300 | N/A |
| Industry | Metal Fabrications | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.5B |
| IPO Year | 2014 | 2005 |
| Metric | RYZ | ATRC |
|---|---|---|
| Price | $23.87 | $31.51 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 7 |
| Target Price | N/A | ★ $51.17 |
| AVG Volume (30 Days) | 499.5K | ★ 1.0M |
| Earning Date | 05-06-2026 | 05-05-2026 |
| Dividend Yield | ★ 2.82% | N/A |
| EPS Growth | N/A | ★ 74.74 |
| EPS | N/A | N/A |
| Revenue | N/A | ★ $201,630,000.00 |
| Revenue This Year | $75.79 | $15.27 |
| Revenue Next Year | $2.17 | $12.21 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 15.40 |
| 52 Week Low | $19.34 | $25.36 |
| 52 Week High | $30.85 | $43.18 |
| Indicator | RYZ | ATRC |
|---|---|---|
| Relative Strength Index (RSI) | 33.26 | 64.81 |
| Support Level | $23.47 | $30.77 |
| Resistance Level | $29.08 | $32.56 |
| Average True Range (ATR) | 1.22 | 1.44 |
| MACD | -0.60 | 0.31 |
| Stochastic Oscillator | 6.70 | 99.40 |
Ryerson Holding Corp provides a metals service center, and value-added processor and is a distributor of industrial metals with operations in the United States, Canada, and Mexico. In addition to its North American operations, it conducts processing and distribution operations in China. It carries a full line of products in stainless steel, aluminum, carbon steel, and alloy steels and a limited line of nickel and red metals in various shapes and forms. The company has one operating and reportable segment, metals service centers. It derives substantially all of its sales from the processing and distribution of met. Geographically, the majority revenue is generated from the United States.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation, Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.